References
1. Morice P, Leary A, Creutzberg C, Abu-Rustum N, Darai E. Endometrial
cancer. Lancet (London, England) 2016; 387 (10023):
1094-108.
2. Kitchener H, Swart AM, Qian Q, Amos C, Parmar MK. Efficacy of
systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC
trial): a randomised study. Lancet (London, England) 2009;373 (9658): 125-36.
3. Benedetti Panici P, Basile S, Maneschi F, et al. Systematic pelvic
lymphadenectomy vs. no lymphadenectomy in early-stage endometrial
carcinoma: randomized clinical trial. Journal of the National
Cancer Institute 2008; 100 (23): 1707-16.
4. Bogani G, Dowdy SC, Cliby WA, Ghezzi F, Rossetti D, Mariani A. Role
of pelvic and para-aortic lymphadenectomy in endometrial cancer: current
evidence. The journal of obstetrics and gynaecology research2014; 40 (2): 301-11.
5. Koh WJ, Abu-Rustum NR, Bean S, et al. Uterine Neoplasms, Version
1.2018, NCCN Clinical Practice Guidelines in Oncology. Journal of
the National Comprehensive Cancer Network : JNCCN 2018; 16 (2):
170-99.
6. Colombo N, Preti E, Landoni F, et al. Endometrial cancer: ESMO
Clinical Practice Guidelines for diagnosis, treatment and follow-up.Annals of oncology : official journal of the European Society for
Medical Oncology 2013; 24 Suppl 6 : vi33-8.
7. Kim HS, Suh DH, Kim MK, Chung HH, Park NH, Song YS. Systematic
lymphadenectomy for survival in patients with endometrial cancer: a
meta-analysis. Japanese journal of clinical oncology 2012;42 (5): 405-12.
8. Colombo N, Creutzberg C, Amant F, et al. ESMO-ESGO-ESTRO Consensus
Conference on Endometrial Cancer: diagnosis, treatment and follow-up.Annals of oncology : official journal of the European Society for
Medical Oncology 2016; 27 (1): 16-41.
9. Cragun JM, Havrilesky LJ, Calingaert B, et al. Retrospective analysis
of selective lymphadenectomy in apparent early-stage endometrial cancer.Journal of clinical oncology : official journal of the American
Society of Clinical Oncology 2005; 23 (16): 3668-75.
10. Ignatov A, Ivros S, Bozukova M, Papathemelis T, Ortmann O, Eggemann
H. Systematic lymphadenectomy in early stage endometrial cancer.Archives of Gynecology and Obstetrics 2020; 302 (1):
231-9.
11. Bougherara L, Azaïs H, Béhal H, et al. Does lymphadenectomy improve
survival in patients with intermediate risk endometrial cancer? A
multicentric study from the FRANCOGYN Research Group.International journal of gynecological cancer : official journal
of the International Gynecological Cancer Society 2019; 29 (2):
282-9.
12. Keys HM, Roberts JA, Brunetto VL, et al. A phase III trial of
surgery with or without adjunctive external pelvic radiation therapy in
intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology
Group study. Gynecologic oncology 2004; 92 (3): 744-51.
13. Lutman CV, Havrilesky LJ, Cragun JM, et al. Pelvic lymph node count
is an important prognostic variable for FIGO stage I and II endometrial
carcinoma with high-risk histology. Gynecologic oncology 2006;102 (1): 92-7.
14. Seagle BL, Gilchrist-Scott D, Graves S, Strohl AE, Nieves-Neira W,
Shahabi S. Association of Lymph Node Count and Overall Survival in
Node-Negative Endometrial Cancers. JCO clinical cancer
informatics 2017; 1 .
15. Sharma C, Deutsch I, Lewin SN, et al. Lymphadenectomy influences the
utilization of adjuvant radiation treatment for endometrial cancer.American journal of obstetrics and gynecology 2011;205 (6): 562.e1-9.
16. Abu-Rustum NR, Alektiar K, Iasonos A, et al. The incidence of
symptomatic lower-extremity lymphedema following treatment of uterine
corpus malignancies: a 12-year experience at Memorial Sloan-Kettering
Cancer Center. Gynecologic oncology 2006; 103 (2): 714-8.
17. Coronado PJ, Rychlik A, Martínez-Maestre MA, et al. Role of
lymphadenectomy in intermediate-risk endometrial cancer: a matched-pair
study. Journal of gynecologic oncology 2018; 29 (1): e1.
18. Todo Y, Kato H, Kaneuchi M, Watari H, Takeda M, Sakuragi N. Survival
effect of para-aortic lymphadenectomy in endometrial cancer (SEPAL
study): a retrospective cohort analysis. Lancet (London, England)2010; 375 (9721): 1165-72.
19. Ouldamer L, Bendifallah S, Body G, et al. Call for Surgical Nodal
Staging in Women with ESMO/ESGO/ESTRO High-Intermediate Risk Endometrial
Cancer: A Multicentre Cohort Analysis from the FRANCOGYN Study Group.Annals of surgical oncology 2017; 24 (6): 1660-6.
20. Nugent EK, Bishop EA, Mathews CA, et al. Do uterine risk factors or
lymph node metastasis more significantly affect recurrence in patients
with endometrioid adenocarcinoma? Gynecologic oncology 2012;125 (1): 94-8.
21. Abu-Rustum NR, Gomez JD, Alektiar KM, et al. The incidence of
isolated paraaortic nodal metastasis in surgically staged endometrial
cancer patients with negative pelvic lymph nodes. Gynecologic
oncology 2009; 115 (2): 236-8.